EE Impact

Baxter International: Russia Operations Status & Business Impact

USA · Pharma & Healthcare

LeaveRussia detail: Suspension

Operations suspended

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions.

Status last verified 03/08/2026Source checked 17/05/2024Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 08/05/2024 · Reference ↗

The US drugmaker Baxter, one of the largest suppliers of dialysis solutions, has suspended its commercial activities in Russia, according to recent statements made in the company’s explanatory note to the annual financial statements of its Russian subsidiary for 2023.

Status history since 2022

  1. 03/08/2026 suspended · Imported from KSE LeaveRussia

Exposure profile

Get alerts if this company's Russia status changes

7-day Pro trial includes watchlists for companies you track. No credit card. Full exposure maps are on Professional after the trial.

Start 7-day Pro trial

Geopolitical context and sanctions impact

Baxter International is a Pharma & Healthcare company based in USA. Current Russia status in our dataset is suspended: paused activity does not always mean a clean legal exit — licences, local entities and unpaid obligations can remain. Eastern Europe Impact translates those facts into business consequences — sanctions screening, supply-chain exposure and reconstruction-side opportunity — with transparent confidence labels rather than speculation.

Risk assessment and how to use this profile

Start with the status badge and decision trail, then check possible sanctions matches and recent events mentioning Baxter International. A 7-day Pro trial adds watchlists so you are notified if Russia status, designations or linked events change. Full exposure maps (energy, transport, commodities) are on Professional. This page is risk information, not legal or investment advice.

Questions about Baxter International

What kind of data does Eastern Europe Impact provide on Baxter International?

Eastern Europe Impact publishes verified intelligence on Baxter International's Russia status: current operating posture, sources (including the KSE LeaveRussia project), status history since 2022, sanctions-list matches, and linked events. Each profile is risk information for compliance and due diligence — not legal advice.

How can Eastern Europe Impact data on Baxter International help my business?

Use the Baxter International profile to check counterparties, suppliers and customers for Russia exposure, sanctions proximity and recent events before you contract, ship or invest. Watchlists alert you if the status or designations change.

How do we verify the information on Baxter International?

We compile public reporting, company statements and the KSE LeaveRussia dataset, then label uncertainty. Status is not a legal determination — verify against primary filings and counsel before acting. Corrections go to corrections@easterneuropeimpact.com.

How much does Eastern Europe Impact cost?

The company checker is free. A 7-day Pro trial (no credit card) unlocks live Daily Impact Briefs, full event profiles and watchlists. After the trial, Individual is €19/month; Professional and Business add exposure maps, sanctions entity pages and API access. See /pricing.
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.
Baxter International: Russia Operations Status, Sanctions & Business Impact (2026) | Eastern Europe Impact